Quick Answer
Nuo Therapeutics, Inc. reported Total Revenue of $721.0 thousand for fiscal year 2017.
Nuo Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2017 | $721.0K | -93.7% |
| 2015 | $11.51M | +48.3% |
| 2014 | $7.76M | -32.9% |
| 2013 | $11.57M | +9.5% |
| 2012 | $10.56M | +45.8% |
| 2011 | $7.25M | +85.3% |
| 2010 | $3.91M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | $162.2K | -8.2% | -14.0% |
| June 30, 2017 | $188.6K | +39.9% | +9.2% |
| March 31, 2017 | $172.7K | -87.7% | -2.3% |
| September 30, 2016 | $176.8K | -91.9% | +31.1% |
| June 30, 2016 | $134.9K | -95.3% | -90.4% |
| March 31, 2016 | $1.41M | -70.9% | -35.1% |
| September 30, 2015 | $2.17M | +28.2% | -25.1% |
| June 30, 2015 | $2.90M | +24.5% | -40.1% |
- Nuo Therapeutics, Inc. showed a decrease of -93.7% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2017 period, Nuo Therapeutics, Inc.’s total revenue has declined by 81.6% (from $3.91 million to $721.0 thousand).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2017 report (Form 10-K), filed with the SEC on April 16, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: